Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Masked, Placebo Controlled Study to Assess the Safety and Efficacy of Darbepoetin Alfa Administered to Preterm Infants

NCT00334737 is registered in ClinicalTrials.gov with University of New Mexico as lead sponsor.

NCT NCT00334737
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00334737 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Masked, Placebo Controlled Study to Assess the Safety and Efficacy of Darbepoetin Alfa Administered to Preterm Infants
Lead sponsor
University of New Mexico
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2006
Completion date
June 30, 2014
Enrollment
102 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

infant, newborn